PHBI - Pharmagreen Biotech Provides Updates on Its Ongoing Business Developments
Carson City, Nevada--(Newsfile Corp. - March 24, 2022) - Pharmagreen Biotech, Inc., (OTCQB: PHBI), ("Pharmagreen" or the "Company") is pleased to report ongoing business developments with Long Valley Farms ("LVF") while completing its fundraising for the acquisition. LVF is continuing its applications processes for the nursery license as well as the micro-business license which will give it the ability to operate from starter plantlets to cultivation, to manufacturing, to distribution, and to...
2022-03-24 10:06 AM EDT
PHBI Pharmagreen Announces Another Milestone Completed Towards the Acquisition of Long Valley Farms LLC
Carson City, Nevada--(Newsfile Corp. - January 20, 2022) - Pharmagreen Biotech, Inc. (OTCQB: PHBI) ("Pharmagreen" or the "Company"), is pleased to announce that it completed another significant milestone towards the acquisition of Long Valley Farms. The Company made another payment to Long Valley Farms and the use of proceeds went towards final payment for the 12 acres of land, which Pharmagreen intends to acquire. With this payment to the third party lender, this installment note on the...
2022-01-20 8:00 AM EST
PHBI Pharmagreen Announces Affirmed MOU to Acquire Licensed California Cannabis Company
Carson City, Nevada--(Newsfile Corp. - January 6, 2022) - Pharmagreen Biotech, Inc., (OTCQB: PHBI), today announced an affirmed memorandum of understanding (MOU) to acquire Long Valley Farms LLC, a California-based cannabis company. The acquisition includes land, infrastructure, and a Cannabis cultivation license for the operation of a cannabis business in the State of California.This acquisition is a strategic component of Pharmagreen's strategy to convert the revenue potential of its proven...
2022-01-06 8:00 AM EST
Pharmagreen Biotech Announces Up-Listing to OTCQB Venture Market
Carson City, Nevada--(Newsfile Corp. - December 21, 2021) - Pharmagreen Biotech Inc., (OTCQB: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD Hemp and Cannabis Industries, is pleased to update its shareholders on its application for up-listing from the OTC Pinks. Further to the News Release of November 4, 2021, the company reports that the application to upgrade to OTCQB has been approved and became effective on Monday, December 20, 2021. We...
2021-12-21 10:06 AM EST
Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset
Carson City, Nevada--(Newsfile Corp. - December 2, 2021) - Pharmagreen Biotech, Inc., (OTC Pink: PHBI), today released a management update from CEO Peter Wojcik. The update is the first in a series of narratives breaking out the company's strategy as it begins to convert the revenue potential of its proprietary intellectual property into realized revenue. The update is included in its entirety below:CEO Peter Wojcik Strategic UpdatePharmagreen has reached an exciting transition stage where...
2021-12-02 7:00 AM EST
Pharmagreen Prepares for Entry Into the Multi-Billion Dollar California Cannabis Industry
Carson City, Nevada--(Newsfile Corp. - November 11, 2021) - Pharmagreen Biotech, Inc., (OTC Pink: PHBI), is pleased to announce that in advance of its entry into the multi-billion dollar California cannabis industry and the development of its Tissue Culture Centre, the company has engaged its research and development corporate partner to commence developing tissue culture protocol for each of the top Cannabis Strains sold and grown in California. This cannabis market is estimated to be over...
2021-11-11 7:30 AM EST
Pharmagreen Submits Its Application for Uplisting to the OTCQB Venture Market
Carson City, Nevada--(Newsfile Corp. - November 4, 2021) - Pharmagreen Biotech, Inc. (OTC PINK: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD Hemp and Cannabis Industries, is pleased to update its shareholders that it has submitted its application to up list to the OTCQB Venture Market. The company's management believes uplisting its common stock to the OTCQB will serve to improve the company's position in the public markets and substantially...
2021-11-04 7:00 AM EDT
Pharmagreen Provides Update on Funding and Acquisition Progress
Carson City, Nevada--(Newsfile Corp. - September 29, 2021) - Pharmagreen Biotech, Inc., (OTC Pink: PHBI), is pleased to update its shareholders on the company's Regulation A offering and ongoing progress with the California acquisition previously announced in a news release published on August 12, 2021. The SEC's notice of qualification with respect to the Reg A offering was issued on September 24, 2021. A portion of the proceeds from this offering will be used to complete the acquisition of...
2021-09-29 7:00 AM EDT
Pharmagreen Signs MOU to Acquire a California Based Cannabis Company
Carson City, Nevada--(Newsfile Corp. - August 12, 2021) - Pharmagreen Biotech, Inc., (OTC Pink: PHBI), is pleased to update its shareholders on the company's developments and progress. Our business development has reached the next milestone with the signing of an MOU (Memorandum Of Understanding), on July 25, 2021, to acquire all the assets (includes property, structures and cannabis licences) and further develop a state of the art flowering greenhouse of approximately 12,000 sq ft or the...
2021-08-12 8:00 AM EDT
Pharmagreen Removes Convertible Debt From Its Balance Sheet
Carson City, Nevada--(Newsfile Corp. - March 23, 2021) - Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to announce that it has signed a settlement agreement with one of the convertible note lenders to cease and desist any future conversions and considers this matter closed going forward. The settlement agreement was submitted to the SDNY courts for immediate dismissal of the proceeding and was so ordered. The company filed an 8-K on March 22, 2021.Additionally the company is happy...
2021-03-23 7:00 AM EDT
Pharmagreen Provides Significant Scientific Development Updates
Carson City, Nevada--(Newsfile Corp. - July 28, 2020) - Pharmagreen Biotech, Inc. (PHBI), a company specializing in the development of high quality tissue cultured starter plantlets for the cannabis and hemp industry, is pleased to provide a scientific development update. Since December 2019 the company's strategic research and development partner, Botanical Research In Motion Inc. (B.R.I.M.), has continued very successful growing trials with "CBD Dana" hemp strain, and, on March 19, 2020,...
2020-07-28 6:00 AM EDT
Pharmagreen CEO Provides Corporate Update, On Verge of Milestone
Carson City, Nevada--(Newsfile Corp. - July 6, 2020) - Pharmagreen Biotech, Inc. (OTC Pink: PHBI), a company specializing in the development of highest quality tissue cultured starter plantlets for the cannabis and hemp industry, is pleased to formally announce the creation of Pharmagreen Inc.'s ETN (Exchange Traded Note) asset-backed bond (the "PHBI ETN Bond"). The Company retained the professional services of Selected Listings, Inc. (the "Listings Agent") to assist with the process.The...
2020-07-06 6:00 AM EDT
Pharmagreen Selects ICF (Insulated Concrete Forms) Building Technology for the Construction of its Cannabis Biotech Complex Building Material
Carson City, Nevada--(Newsfile Corp. - January 16, 2020) - Pharmagreen Biotech, Inc. (OTC Pink: PHBI) is pleased to announce today that it signed a memorandum of understanding with Here to Serve Holding Corp., (OTC: HTSC) to provide consulting services and supply ICF building material (Insulated Concrete Forms) for the construction of Pharmagreen's 63,000 square foot facility, the Cannabis Biotech Complex.The complex, which will take about 18 months to construct, makes use of cutting edge...
2020-01-16 8:00 AM EST
Pharmagreen Provides Update
Carson City, Nevada--(Newsfile Corp. - December 12, 2019) - Pharmagreen Biotech, Inc., (OTC Pink: PHBI), is pleased to provide a company development update. The company has secured significant credit facility to date and plans to use the funds to move forward with its projects development to build a state of the art all year round greenhouse and a tissue cultured starter plantlet production facility. The all year round greenhouse was added to the company's plans for a first...
2019-12-12 9:00 AM EST
Pharmagreen Closes $10 Million Equity Purchase Agreement
Carson City, Nevada--(Newsfile Corp. - December 4, 2019) - Pharmagreen Biotech, Inc. (OTC Pink: PHBI) is pleased to announce today that the company executed all the required documents for an Equity Purchase Agreement (the "Equity Agreement") with Oscaleta Partners LLC ("Oscaleta"), as stated earlier in the news release dated November 12, 2019, that should enable Pharmagreen to access capital over the next 2 years to support its current growth plans. The terms of the Equity Agreement will give...
2019-12-04 9:00 AM EST
Pharmagreen Signs Term Sheet for $10 Million Equity Purchase Agreement
Carson City, Nevada--(Newsfile Corp. - November 12, 2019) - Pharmagreen Biotech, Inc. (OTC PINK: PHBI), is pleased to announce today that the company signed a term sheet for an Equity Purchase Agreement (the "Equity Agreement") with Oscaleta Partners LLC ("Oscaleta"), that should enable Pharmagreen to access capital over the next 2 years to support its current growth plans. The terms of the Equity Agreement will give Pharmagreen the right, but NEVER THE OBLIGATION, to sell to Oscaleta up to...
2019-11-12 9:00 AM EST
Pharmagreen Signs a LOI for Supply of CBD Dana Hemp Starter Plantlets
Carson City, Nevada--(Newsfile Corp. - October 4, 2019) - Pharmagreen Biotech, Inc., (OTC PINK: PHBI), is pleased to announce that its Canadian subsidiary, WFS Pharmagreen Inc., has signed a Letter of Intent with Carpere Inc. for the supply of "CBD Dana" hemp starter plantlets for the 2020 farming season and beyond.The Pharmagreen team is excited to work with Carpere to be their supplier of all female high CBD hemp starter plantlets to produce the highest quality high CBD flower...
2019-10-04 9:00 AM EDT
Pharmagreen Receives Positive News from Health Canada on its Cannabis License Application Submission
Carson City, Nevada--(Newsfile Corp. - May 28, 2019) - Pharmagreen Biotech, Inc. (OTC PINK: PHBI), is pleased to announce that its Canadian subsidiary, WFS Pharmagreen Inc., has received notification concerning WFS PHARMAGREEN INC.'s application submitted under the Cannabis Regulations to become a license holder."Health Canada has completed a preliminary and high-level review of the license application. Based on the information assessed, Health Canada has no critical concerns with the...
2019-05-28 7:30 AM EDT
Pharmagreen Grants Alliance Growers Inc. an Option Agreement to Acquire an Equity Interest in the Deroche Cannabis Biotech Complex
Carson City, Nevada--(Newsfile Corp. - January 29, 2019) - Pharmagreen Biotech, Inc. (OTC Pink: PHBI), is pleased to announce that its wholly owned Canadian Subsidiary, WFS Pharmagreen Inc., on January 25, 2019 executed an option agreement with Alliance Growers Inc. This option agreement provides Alliance Growers with an initial 10% equity interest in WFS Pharmagreen subsidiary 1155907 BC Ltd. for an investment of CDN $1,350,000 (received). The option also allows Alliance Growers to earn up...
2019-01-29 9:25 AM EST
Pharmagreen Biotech Provides Commentary on Cannabis Production in North America
Carson City, Nevada--(Newsfile Corp. - November 27, 2018) - Pharmagreen Biotech, Inc., (OTC Pink: PHBI) ("Company") provided commentary on the burgeoning cannabis production market following its recent legalization October 17, 2018. Pharmagreen CEO Peter Wojcik provided the following observations in conjunction with how the Company believes its Cannabis Biotech Complex, currently under construction in B.C., Canada, will help solve the infancy stage production issues facing the...
2018-11-27 11:59 AM EST